Market Reports

Category Archives

Reports on the MMPR Medical Cannabis Market

ACMPR Dried Cannabis Dashboard – April 22 2017

Market Reports

A collection of graphs from our April 22 2017 ACMPR summary

ACMPR Dried Cannabis – 04/22/2017

Market Reports

Cannabinoid content and the price of medical cannabis in Canada vary with licensed producer, location of production, and production method. We track cannabinoid content and pricing data for all available dried cannabis flowers and milled blends to understand how these prices change over time, and to highlight offerings with the best value.

View the full story here:

2017 Canadian Dispensary Dried Cannabis Summary

Market Reports

This summary focuses on dried cannabis pricing in Canadian dispensaries with listings on a popular dispensary menu aggregator. From a pool of over 100,000 dispensary listings, we’re looking to see how the per gram asking price of dried cannabis changes with location and quantity.

block_1block_2block_3block_4block_5block_6block_7block_8block_9block_10block_11block_12block_13block_14block_15block_16block_17block_18block_19block_20block_21block_22block_23block_24

ACMPR Dried Cannabis – 03/30/2017

Market Reports

block_1Cannabinoid content and the price of medical cannabis in Canada vary with licensed producer, location of production, and production method. We track cannabinoid content and pricing data for all available dried cannabis flowers and milled blends to understand how these prices change over time, and to highlight offerings with the best value.

block_2

The data for this summary was taken March 30th 2017. Publicly available information on producer websites and newsletters was logged for all available dried cannabis flower and blends in the ACMPR. Actual cannabinoid content and non-compassionate price were logged for each listing and, in the cases where ranges of cannabinoids were given, midpoint averages were used. For the producers offering volume discounts, we’ve used the cost for the smallest size available. We do not show sales tax, shipping, or pricing incentives for ordering an entire month’s prescription in one order. In cases where the same variety was offered by two different providers, and for varieties that were available in whole flower and blended form, data was logged for each instance.

block_4

All flower and blended dried cannabis offerings were categorized according to cannabinoid content. Offerings with ratios of 1.4+ THC:CBD were considered THC offerings. Those with 1.4-0.3 THC:CBD were considered 1:1 offerings, while the remainder (<0.3 THC:CBD) were considered CBD offerings.

 

There were 155 dried cannabis blends and flowers available from the 22 Licensed Producers providing cannabis to ACMPR patients. The average number of selections per producer is just over 7—a slight decrease from earlier this month. Most producers (21 of 22) carried at least 5 THC offerings and at least one offering containing some amount of CBD. Varieties containing negligible amounts of THC (compared to CBD) were available from 7 of 22 providers (up from 6 last in early March).

We want to note that we’ve omitted Hydropothecary’s line of fully decarboxylated dried cannabis designed for oral ingestion from previous studies. They are now included in this study. Although the product is designed to be taken as an edible, it is still categorized as dried cannabis. These products are unique in the market currently and, we’ll start to compare them against other fully decarboxylated dried product as they become available.

block_5

Of the 155 available offerings, 122 of them (79%) contained significant amounts of THC to CBD. Seven of the 155 (4.5%) were found to have significant amounts of CBD with negligible amounts of THC. The remaining 17% were found to be 1:1 offerings with comparable cannabinoid content (26 offerings).

 

The average price per gram for a gram of cannabis in the ACMPR was found to be $9.12.
block_6

Looking at price with respect to cannabinoid content, the average price for 100mg of THC is $5.02. Per producer, prices ranged from $2.83 to $7.81 per 100 milligrams of THC.

 

Prices are typically higher for CBD chemotypes: the average price of 100mg of CBD was $7.39 for the second half of March. Average prices per producer remained the same as earlier this month, and ranged from $5.92 to $10.00 per 100 milligrams of CBD.

block_7

For 100mg of THC/CBD from a 1:1 chemotype, the average price is $5.36. Producer averages ranged from $3.88 to $9.95 per 100 milligrams of either cannabinoid. The maximum end of the range is down from earlier this month where we saw listings for 1:1 chemotypes just above $11.00 per 100 milligrams.

 

We’ve started to track average cannabinoid content for THC and CBD chemotypes. Please note, increasing cannabinoid content does not necessarily equate to increased efficacy.

block_8

For the 21 producers with THC offerings, the average content was 17.9% THC. The minimum and maximum values ranged from 14.3% to 23.0% THC, respectively.

 

For the 7 producers with CBD offerings, the average content was 13.0% CBD. The minimum and maximum values ranged from 9.0% to 16.9% CBD, respectively.

block_9

This summary tracks dried cannabis listings from around the ACMPR. Much of the data presented here is shown as summarized producer averages comprised of several offerings. For specific information on each cannabis variety, as well as information on each producer, check out Lift and read the reviews in the review section.

ACMPR Cannabis Oils – 03/19/17

Market Reports

block_1Cannabinoid content and the price of medical cannabis in Canada vary with licensed producer, location of production, and production method. We track cannabinoid content and pricing data for all available cannabis oils to understand how these prices change over time, and to highlight offerings with the best value.
block_2

Publicly available information from licensed producer websites was logged March 19th 2017 for all available cannabis oils in the ACMPR. Potential THC and CBD content was logged from each producer website. In cases where percent values were given, the datum was converted to mg/mL units. Cannabinoid ratios with dried cannabis are used for producers that do not show actual medicinal content of oils. Non-compassionate pricing was taken for each offering, and for LPs offering multiple volumes, we’ve shown the price for the largest volume. Each instance was counted for offerings of the same cannabis oil in different concentrations. Cannabis oils available in two separate forms (oil and capsules) were counted once.
block_3

The number of cannabis oils available to ACMPR patients increased to 62 this month. In total, 15 producers produce oils for their patients, and 14 of these producers had oils available at the time of this scan. All producers with oils available had at least one THC oil in their store. Of the 15 producers, 7 had at least one cannabis oil with significant amounts of CBD (and negligible amounts of THC) available. Eleven of 15 producers had at least one 1:1 offering available with comparable amounts of THC and CBD.

 

Most producers have at least 2 selections of cannabis oils containing significant amounts of THC available. These THC offerings had an average of 23.14 mg/mL of THC. Thirteen percent of the offerings (8 selections) had significant amounts of CBD compared to amounts of THC. These CBD offerings had an average of 19.36 mg of CBD per mL of oil. The remaining 12 (19%) offerings had even or comparable amounts of THC and CBD (1:1 cannabis oils).

block_4

The average price for 10mg of THC was $1.01, down from $1.02 last month. Aphria’s Champlain Indica is the lowest price for THC, at $0.61 per 10mg THC.

 

The average cost for 10mg CBD was $1.49, down from $1.61 last month. For the fourth month in a row, Canntrust’s CBD offering maintains the market minimum price ($0.90 per 10mg). Aphria also had CBD oils priced below $1.00 per 10mg of CBD.

block_5For 10mg of either tetrahydrocannabinol or cannabidiol (THC or CBD) from 1:1 strains the price was $1.23, up from $1.14 when this summary was performed on the 28th of February 2017. The minimum price for THC/CBD cannabinoids from a 1:1 cannabis oil was $0.67, from Aphria’s Capilano Hybrid Oil. Tweed and Canntrust also have selections of oil with prices below the $1.00 mark for 10mg of THC/CBD.

 

For specific information on each cannabis oil, as well as information on each producer, check out Lift.

 

ACMPR Dried Cannabis – 2/22/17

Market Reports

block_1

Cannabinoid content and the price of medical cannabis in Canada vary with licensed producer, location of production, and production method. We track cannabinoid content and pricing data for all available dried cannabis flowers and milled blends to understand how these prices change over time, and to highlight offerings with the best value.

The data for this summary was taken February 22nd 2017 (Delta 9 figures February 21 current). Publicly available information on producer websites and newsletters was logged for all available dried cannabis flower and blends in the ACMPR. THC and CBD content and non-compassionate price were logged for each strain and, in the cases where ranges of cannabinoids were given, midpoint averages were used. Active THC/CBD is used where the information is specified. For the producers offering volume discounts, we’ve used the cost for the smallest size available. In cases where the same strains were offered by two different providers, and for strains that were available in whole flower and blended form, data was logged for each instance.

block_2All flower and blended dried cannabis offerings were categorized according to cannabinoid content. Offerings with ratios of 1.4+ THC:CBD were considered THC offerings. Those with 1.4-0.3 THC:CBD were considered 1:1 offerings, while the remainder (<0.3 THC:CBD) were considered CBD offerings.

There were 158 blends and flowers available from the 21 Licensed Producers in the ACMPR this month. The average number of selections per producer is just over 7—no change from last month. Most producers carried at least 5 THC offerings and at least one 1:1 offering. Strains containing negligible amounts of THC compared to CBD were less available: just 8 of 21 producers carried this type of offering.

block_3Canada’s Island Garden is showing 4 initial offerings on their website. As soon as they release pricing, we’ll include them in this summary.

Of the 158 currently available offerings, 126 of them (80%) contained significant amounts of THC to CBD. As noted above, 8 of the 158 (5.1%) were found to have significant amounts of CBD with negligible amounts of CBD. The remaining 20% were found to be 1:1 offerings with comparable cannabinoid content (32 offerings).

block_4

The average price per gram for a gram of cannabis in the ACMPR was found to be $9.35.
block_5

Looking at price with respect to cannabinoid content, the average price for 100mg of THC is $5.41. Per producer, prices ranged from $3.07 to $8.57 per 100 milligrams of THC.

block_6Prices are typically higher for CBD strains: the average price of 100mg of CBD was $7.19 this month. Average prices per producer ranged from $5.33 to $10.00 per 100 milligrams .

 

For 100mg of THC/CBD from a 1:1 strain, the average price is $5.54. Producer averages ranged from $3.81 to $9.20 per 100 milligrams of either cannabinoid.

 

This summary tracks cannabinoid content and price from around the ACMPR. Much of the data presented here is shown as a summarized producer average comprised of several offerings. For strain specific information, as well as information on each producer, check out Lift and read the reviews in the review section.

 

ACMPR Cannabis Oils – 1/27/17

Market Reports

block_1Cannabinoid content and the price of medical cannabis in Canada vary with licensed producer, location of production, and production method. We track cannabinoid content and pricing data for all available cannabis oils to understand how these prices change over time, and to highlight offerings with the best value.

block_2Publicly available information from licensed producer websites was logged for all available cannabis oils in the ACMPR. The data for this summary was taken January 27th 2017, and only available offerings were included. Potential THC and CBD content were logged from each website and averaged in the cases where ranges were given. In cases where percent values were given, the datum was converted to mg/mL units. Ratios are used for producers that do not show actual medicinal content of oils. Non-compassionate pricing was taken for each offering, and for LPs offering multiple volumes, we’ve shown the price for the largest volume. In cases where the same strains were offered by two different providers, data was logged for each separate instance. Each instance was counted for offerings of the same cannabis oil available in two different forms or concentrations (oil and capsules).

block_3The data for this summary was taken January 27th 2017. Publicly available information on producer websites and newsletters was logged for all available cannabis oils in the ACMPR. THC and CBD content and non-compassionate price were logged for each selection and, in the cases where ranges of cannabinoids were given, midpoint averages were used. In cases where percent values were given, the datum was converted to mg/mL units.

 

The number of cannabis oils available to ACMPR patients increased back up to 56, up three from last month’s count. In total, 14 producers produce oils for their patients, and 13 of these producers had oils available at the time of this scan. All producers with oils available had at least one THC oil in their store. Of the 14 producers, 7 had at least one cannabis oil with significant amounts of CBD available (down from 10 last month). The average number of selections has been consistent for 3 months in a row—four per licensed producer—although maximum and minimum values ranged from 18 to 0 oils. Once again, approximately one-third of all 53 cannabis oils are produced by Whistler.
block_4

Sixty-four percent of the total number of cannabis oils had significant amounts of THC compared to other cannabinoids (down from 71% last month). Over 20% of the offerings (12 selections) had significant amounts of CBD compared to amounts of THC. The remaining 8 (14%) offerings had even or comparable amounts of THC and CBD (1:1 cannabis oils).

 

The average price for 10mg of THC was $1.13, down from $1.26 last month. Tweed’s Zaius consistently ranks as the lowest price for THC, at $0.62 per 10mg THC.

block_5The averages price of cannabis oils containing significant amounts of CBD has fluctuated slightly over the past few months as availability fluctuated. The average cost for 10mg CBD was $1.67, down from $2.00 last month. For the second month in a row, Canntrust’s CBD offering maintains the market minimum price ($0.90 per 10mg).

 

Cannabis oils with even THC and CBD ratios had the highest price per medical content. Average prices also fluctuate with availability: for 10mg of cannabinoids (THC or CBD) from 1:1 strains the price was $1.82; up from $1.18 when this summary was performed last month. For the second month in a row, the minimum price for THC/CBD cannabinoids from a 1:1 cannabis oil was $0.78, from Bedrocan’s Bediol.

 

For specific information on each cannabis oil, as well as information on each producer, check out Lift.

 

ACMPR Dried Cannabis – 1/11/17

Market Reports

 

block_1Cannabinoid content and the price of medical cannabis in Canada vary with licensed producer, location of production, and production method. We track cannabinoid content and pricing data for all available dried cannabis flowers and milled blends to understand how these prices change over time, and to highlight offerings with the best value.

block_2The data for this summary was taken January 11th 2017 (Delta 9 figures January 10 current). Publicly available information on producer websites and newsletters was logged for all available dried cannabis flower and blends in the ACMPR. THC and CBD content and non-compassionate price were logged for each strain and, in the cases where ranges of cannabinoids were given, midpoint averages were used. For the producers offering volume discounts, we’ve used the cost for the smallest size available. In cases where the same strains were offered by two different providers, and for strains that were available in whole flower and blended form, data was logged for each instance.

 

All flower and blended dried cannabis offerings were categorized according to cannabinoid content. Offerings with ratios of 1.4+ THC:CBD were considered THC offerings. Those with 1.4-0.3 THC:CBD were considered 1:1 offerings, while the remainder (<0.3 THC:CBD) were considered CBD offerings.

block_3There were 161 blends and flowers available from the 21 Licensed Producers in the ACMPR, up from 155 offerings from December 16 2016. The average number of selections per producer is 7 —  no change from last month. Most producers carried at least 5 THC offerings, some doubled this average (Hydropothecary and Whistler) while others had one (Aurora, Mettrum) or none (Tweed). Five percent of strains had significant amounts of CBD and negligible amounts of CBD, offered from a third of the producers (Aphria, Aurora, Bedrocan, CanniMed, Canntrust, Hydropothecary, MedReleaf and Tweed). On average, each producer carried a 1:1 strain with significant amounts of THC and CBD, while some had as high as 3 choices (AB Cann, Canna Farms, Hydropothecary, MariCann and Tweed).

 

Hydropothecary has several new offerings included in the scan this week. Notably, they offer a decarboxylated cannabis product that has been milled and prepared for oral consumption via the provided capsules.

block_4

Of the 161 currently available offerings, 123 of them (76%) contained significant amounts of THC to CBD. As noted above, 8 of the 161 (5.0%) were found to have significant amounts of CBD with negligible amounts of CBD. The remaining 19% were found to be 1:1 offerings with comparable cannabinoid content.

 

The average price per gram for a gram of cannabis in the ACMPR was found to be $9.09, up $0.07 from our December 16 2016 scan.
block_5

Looking at price with respect to cannabinoid content, the average prices for 100mg of THC rose slightly from $5.42 to $5.72. Per producer, prices ranged from $3.45 to $9.50 per 100 mg, with Redecan, Aurora and Bedrocan showing lowest averages for 100mg of THC.

block_6

This month, 24% of THC offerings (30 of the 123 offerings) claimed above 20% THC. The average THC content for THC offerings was 17%.

 

Prices are typically higher for CBD strains: the average price of 100mg of CBD was $7.44 this month, down from $8.14 last month. Average prices per producer ranged from $4.21 to $10.34, with Aurora and CanniMed being the lowest cost providers.

 

Cannabinoid prices from 1:1 offerings have also increased. For 100mg of THC/CBD from a 1:1 strain, the average price is $5.73, up from $5.47 last month. Producer averages ranged from $3.35 to $10.20, with Redecan showing the lowest average prices.

 

This summary tracks cannabinoid content and price from around the ACMPR. Much of the data presented here is shown as a summarized producer average comprised of several offerings. For strain specific information, as well as information on each producer, check out Lift and read the reviews in the review section.

 

CBD – 06/25/16

Market Reports

mmpr-cbd-report_block_1mmpr-cbd-report_block_2mmpr-cbd-report_block_3mmpr-cbd-report_block_4mmpr-cbd-report_block_5mmpr-cbd-report_block_6 mmpr-cbd-report_block_7mmpr-cbd-report_block_8mmpr-cbd-report_block_9mmpr-cbd-report_block_10mmpr-cbd-report_block_11mmpr-cbd-report_block_12mmpr-cbd-report_block_13mmpr-cbd-report_block_14mmpr-cbd-report_block_15 mmpr-cbd-report_block_16mmpr-cbd-report_block_17mmpr-cbd-report_block_18mmpr-cbd-report_block_19mmpr-cbd-report_block_20mmpr-cbd-report_block_21mmpr-cbd-report_block_22mmpr-cbd-report_block_23mmpr-cbd-report_block_24mmpr-cbd-report_block_25 mmpr-cbd-report_block_26mmpr-cbd-report_block_27mmpr-cbd-report_block_28mmpr-cbd-report_block_29mmpr-cbd-report_block_30

THC – 06/25/16

Market Reports

mmpr-thc-report-june-25-2016_block_1

This report focuses on strains being sold under the Canadian MMPR with high quantities of THC and low quantities of CBD. Some strains will have levels of CBD considered to be higher (>3.5%) but are still categorized as THC facing strains for their high levels of THC.

We track and analyze metrics for medical cannabis available under the Canadian Marijuana for Medical Purposes Regulations. We primarily concentrate on collecting secondary quantitative information currently but look to expand our scope to other areas of analysis in the near future.

In our last report, we wanted to start by orienting ourselves with the logic behind selecting valuable cannabis, the metrics used to measure cannabis and their respective restrictions. This report looks at THC content and THC content with respect to price for all strains available in the MMPR. THC is one indicator of the value and potency for cannabis, however, it should be understood that cannabis potency as an function of THC% is greatly modified by the terpene composition of the strain, in a number of ways including tolerance, neurotransmitter activity and overall medicinal quality. For example, strain X with 20% THC  and a large amount of terpene Z will behave very differently than strain B with 20% THC and a large about of terpene C. Moreover, strain X1 with 30%THC and low levels of terpene Z could have comparatively lower medicinal qualities than strain X2 with 20%THC and a large amount of terpene Z.

Another disclaimer to mention here is the scientific equipment and methodology used to determine these values can be associated with large degrees of error. Because the data being used in this report comes from 18 different sources, each with their own unknown degree of error; inaccuracy is very likely. Particularly when we are comparing strains with comparable content (~5-10%THC). So when we look at the ‘top 11 strains’, it’s better to look at them collectively, not comparatively. A 25% OG Kush, a 21% Jack Herer and a 19% Bubba Kush will all behave very differently and will need to be investigated exclusively by each individual.

Also, it’s important to mention that purveyors of fine cannabis do not select on the basis of numerical THC content alone. In actual fact, THC % rarely factors in to the decision making process. Key individuals in the cannabis community have noted this and have brought it to our attention and, as we have historically selected cannabis based on the growth mechanism and by using our sense of scent, sight and touch (in that order), we tend to agree.

As patients, we must procure medical cannabis for ourselves over the internet or telephone. We are given pictures and a short description with THC%, CBD% and (sometimes) the true name of the cannabis strain. Terpene information is steadily coming and branding/marketing will become a larger factor soon. Right now, I tend to select based on my past experience/knowledge of each strain and percent content of THC/CBD. Once I find a reliable strain, I tend to include it in the rotation with other reliable strains.

There are two main drivers of this behaviour: crude grams are limited per month and medical cannabis is expensive. To fully take advantage of my limit, my attempt is to use the least amount of crude cannabis material with the highest medical content, so I tend to gravitate to higher THC strains and those I know work for me. I also factor in per gram pricing with respect to THC content. This is an erroneous methodology suitable only for purchasing online. If I were buying in-person, I would ask how it was grown and smell it before asking about THC%.

So to put this all into context, let’s pretend we’re going to play darts. We’re going to throw the darts through some hula-hoops that may stray the dart’s path; but we don’t get to know if that has happened or not. Also, we don’t even get to see where the darts land; someone from a profit driven company is going to tell us. And, there’s nobody on the other side that really cares exactly what the company guys tell us about the darts’ position. Oh and we’re all going to play for some money and, for some people, your health.

We stick to quantifiable metrics within definable markets. Our attempt is to analyze and process information in an accurate and transparent manner while highlighting all degrees of inconsistencies. This industry can only benefit from further transparency and accountability. We thank those who have questioned and contributed to us along that basis.

Let’s get into the market this week:

mmpr-thc-report-june-25-2016_block_2

Let’s look at all 127 strains graphed alphabetically:

mmpr-thc-report-june-25-2016_block_4

Below, we’re looking at the strains and blends with THC content. First, let’s talk about the restrictions associated with this list:

First, scientific methodology used for testing can have large degrees of error http://www.canorml.org/RingTestOShaughnessys_Aut11.pdf ; sometimes as high as 15%.

Secondly, some LPs use ranges of THC and some use static values. For example, MedReleaf uses ranges for their Eran Almog which we average at 27.5%. The maximum end of this range is 29% and the minimum is 26% THC. In fact, ranges are likely more true to the nature of the cannabis plant as buds have THC and terpene contents relative to their position on the plant; buds near the apical meristem are likely to have higher contents.

Thirdly, these strains are not comparable. Querkle and Super Lemon Haze aren’t comparable strains; they both do different things. Furthermore, Querkle grown in two different environments by two different people will be similar at best. This is largely related to their terpene content but can also be related to growing medium, lighting and shipping method. If you believe in the depth of craft like we do, we’d also say the love and pride put into each plant shows in the end product. So it’s important to do your own qualitative research using other sources; we like Lift.

www.liftcannabis.ca

 

mmpr-thc-report-june-25-2016_block_6

As mentioned above, all these strains are good. Actually there are 49 strains above 20% THC in the market right now and the majority are likely to have some facet that makes them unique and exceptional. If price is not a restriction for you, most strains above 20% THC are good bets from your respective provider.

Let’s look at the range in THC as a whole for all 127 strains and blends. Not a lot of movement has happened from this week over last week. The bookends of the market remain the same and the average has decreased 0.1% THC.

mmpr-thc-report-june-25-2016_block_8

Although the number of strains remained relatively consistent over last week, the average price per gram increased $0.04 over last week. This increase is non-consequential (>1%).

mmpr-thc-report-june-25-2016_block_10

We use the THC% for all strains and blends to calculate the price of 75 mg of THC from that particular strain. We like to look at THC in 75mg portions because it allows for rough price comparison and on average, this equates to ~300mg of  dried cannabis material. This is relevant to vaporizing or smoking whole flower cannabis but not to edibles.

mmpr-thc-report-june-25-2016_block_12

With a slight increase in per gram pricing and a similar decrease in price for 75mg THC, on average THC facing strains and blends in the market have slightly more THC for less price.

Let’s look at each licensed producer and average their offerings according to price for 75mg of THC. Minimum price is shown on the left and maximum price on the right with average values equidistant between the two.

Most LPs have economical options available under the $4 mark; just above the market average. Four LPs compete around the $1-2 range with their blends and less expensive strains. The bulk of the competitive market exists in the $2-3 range, just below market average.

Certain LPs such as Bedrocan, Aurora, Aphria and Peace Naturals have a relatively flat pricing structure with respect to THC content; their maximum and minimum prices do not deviate largely from their average prices. Other LPs like Cannafarms, MedReleaf and Maricann have large deviations from their pricing average, offering strains with both high and low prices (THC comparative). This trend is something to note but we’re not making any comparative assumption for the observation at this point nor do we feel it necessary to make one. Price for THC and actual medicinal value to the individual are very different so again, its important to do your own research from more than one source.

mmpr-thc-report-june-25-2016_block_14

Next, we’ll look at price for THC for the eleven strains with the lowest price for 75mg of THC. Let’s remind ourselves that this data is still associated with the large degrees of error we talked about earlier.

Bottoms by Cannafarms was available at the time the data was taken. It has since become unavailable but we’ve learned it is expected back soon. Comparatively speaking, it offers the best price for THC in the MMPR.

Broken Coast is a popular LP that produces boutique cannabis. We’ve seen it in person; it’s marvellous. Read the reviews on Lift. Both their indica and sativa are a great price for the amount of THC you get. They have whole flower on this list as well, their potent Super Lemon Haze is also a great value.

Headband is a wonderful sativa strain with some decent genetics. Maricann has a offering of the smaller ‘popcorn’ sized buds available for a very economical price.

As always, Bedrocan has their offerings that are always amongst the top for value. We calculate these prices based on their $5/gram pricing, they also offer compassionate pricing at $3/gram.

Querkle by Aurora returns this week at just below 28% THC. This cross of Mendocino Purps and Space Queen produces a nice indica hybrid experience.

mmpr-thc-report-june-25-2016_block_16

We think that access to a large distribution of terpene content is best; so we look at the number of offerings from each LP weekly as well.

mmpr-thc-report-june-25-2016_block_18mmpr-thc-report-june-25-2016_block_19